Allife Medical Science and Technology
Privately held: no public share price
Assets
(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 1 | No discrete molecular targetCell therapy | Atherosclerotic Cardiovascular Disease | |
iPS-NSC cellsNo recent activity | Phase 1 | dopaminergic neuron replacementCell therapy | Parkinson's Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.